Gynecomastia and Its Management In Boys With Partial Androgen Insensitivity Syndrome
The Journal of Clinical Endocrinology & Metabolism · 2025
DOI: 10.1210/clinem/dgae562 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift The Journal of Clinical Endocrinology & Metabolism, 2025. Verfasst von Supitcha Patjamontri und 20 weiteren Autor:innen. Beteiligte Einrichtung: Developmental Endocrinology Research Group, University of Glasgow, Royal Hospital for Children, Glasgow G51 4TF, UK. Hauptthemen laut MEDLINE: Gynecomastia, Androgen-Insensitivity Syndrome. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand, Seventh European Union Framework Program, European Society for Paediatric Endocrinology.
Abstract (Originalsprache)
Introduction
Partial androgen insensitivity syndrome (PAIS) is a rare condition that is reported to be commonly associated with gynecomastia in males.
Objectives
To assess the management of gynecomastia in male PAIS. Materials and Methods Retrospective review of males with PAIS over the age of 10 years in the I-DSD registry.
Results
Of the 205 eligible cases, information was available for 57 from 13 centers. An androgen receptor gene variant was confirmed in 45 (79%) with a median age at first presentation of 1.0 year (range 0.1, 26.0). Of the 45 genetically confirmed cases, gynecomastia was present in 41 (91%) with a median age at the time of gynecomastia development of 13.5 years (11.0, 29.0). In the other 4 (9%) with no gynecomastia, the median age at last assessment was 15.7 years (10.6, 17.0). In 30 cases with information available, micropenis was present at the time of gynecomastia development in 23 (77%). Of the 35 with information available, 2 (6%) exhibited spontaneous resolution between the ages of 15 and 21 years and 25 (71%) had breast surgery at a median age of 15.7 years (14.0, 23.0). Of these 25, 9 (26%) had previously received medical therapy. The median clinician score of effectiveness for medical therapy was 3 (1, 8) compared to 10 (3, 10) for surgery (P < .0001). In 31 with information available, 13 (42%) had received psychology support.
Conclusion
Gynecomastia is common in PAIS but not universal. Surgical management may be more effective than medical therapy, but there is a need for further standardized and systematic studies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Developmental Endocrinology Research Group, University of Glasgow, Royal Hospital for Children, Glasgow G51 4TF, UK.
- Division of Endocrinology and Metabolism, Department of Pediatrics, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok 10700, Thailand.
- Division of Pediatric Endocrinology, Department of Pediatrics, Sophia Children's Hospital and Center of Expertise DSD, Erasmus University Medical Center, Rotterdam 3000 CA, Netherlands.
- Department of Paediatric Endocrinology, Ghent University Hospital, University of Ghent, Ghent 9000, Belgium.
- Ukrainian Scientific and Practical Center of Endocrine Surgery, Transplantation of Endocrine Organs and Tissues of the Ministry of Health of Ukraine, Kyiv 01021, Ukraine.
- Interdisciplinary Group for the Study of Sex Determination and Differentiation, School of Medical Sciences (FCM), State University of Campinas, Campinas 13083-887, Brazil.
ORCID-Profile: Supitcha Patjamontri, Angela K Lucas-Herald, Martine Cools, Olaf Hiort, Paul-Martin Holterhus, Anders Juul, S Faisal Ahmed
Förderung
- Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand
- Seventh European Union Framework Program
- European Society for Paediatric Endocrinology
- Medical Research Council
Zitieren
APA
Patjamontri, S., Lucas-Herald, A. K., Bryce, J., van den Akker, E., Cools, M., Globa, E., Guerra-Junior, G., Hiort, O., Hofman, P., Holterhus, P. M., Hughes, I. A., Juul, A., Nordenstrom, A., Russo, G., Stancampiano, M. R., Seneviratne, S. N., Tadokoro-Cuccaro, R., Thankamony, A., Weintrob, N., …, & Ahmed, S. F. (2025). Gynecomastia and Its Management In Boys With Partial Androgen Insensitivity Syndrome. The Journal of Clinical Endocrinology & Metabolism. https://doi.org/10.1210/clinem/dgae562
Vancouver
Patjamontri S, Lucas-Herald AK, Bryce J, van den Akker E, Cools M, Globa E, et al. Gynecomastia and Its Management In Boys With Partial Androgen Insensitivity Syndrome. The Journal of Clinical Endocrinology & Metabolism. 2025. doi:10.1210/clinem/dgae562
BibTeX
@article{Patjamontri2025,
author = {Patjamontri, Supitcha and Lucas-Herald, Angela K and Bryce, Jillian and van den Akker, Erica and Cools, Martine and Globa, Evgenia and Guerra-Junior, Gil and Hiort, Olaf and Hofman, Paul and Holterhus, Paul-Martin and Hughes, Ieuan A and Juul, Anders and Nordenstrom, Anna and Russo, Gianni and Stancampiano, Marianna R and Seneviratne, Sumudu N and Tadokoro-Cuccaro, Rieko and Thankamony, Ajay and Weintrob, Naomi and Zelinska, Natalia and Ahmed, S Faisal},
title = {Gynecomastia and Its Management In Boys With Partial Androgen Insensitivity Syndrome},
journal = {The Journal of Clinical Endocrinology & Metabolism},
year = {2025},
doi = {10.1210/clinem/dgae562}
}
EUVIMED